ACADIA Pharmaceuticals Inc. (ACAD) rose 7.47% or 2.01 to $28.93. It is approximately 3.43 million shares traded, which is 212.27% compare to the average total volume 1.62 million. The market cap of ACAD is $3.59 billion. The year to date change is -11.53%. The 52 week price range is from $25.06 to $41.2. Price of ACAD have changed -5.11% during last week. It have changed -6.37% over last month, -24.76% over last 3 months, -11.53% over last 6 months and -11.36% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ACAD is 28.96. It is 0.10% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for ACAD is 31.27. It is 8.09% above current price. The 52-week High is 41.2. It is 42.41% from the current price. The 52-week Low is 25.06. It is -13.38% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ACAD is 7.01 on 2017-12-29. Short % to float is 8.00%. There are some statistics of ACAD. It is has market cap $3.59 billion. The share outstanding is 124.21 million. The average volume is 1.62 million. The revenue is 93.30M. The gross profit is 84.98M. The percent of top 15 Institution holding is 97.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ACAD is -62.64%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ACAD is -58.04%.